Sunshine Biopharma Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Sunshine Biopharma Inc. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $96.90K.
- Sunshine Biopharma Inc. stock issued during period, value, issued for services for the quarter ending 2023-12-31 was $0.00.
- Sunshine Biopharma Inc. stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $0.00.
- Sunshine Biopharma Inc. stock issued during period, value, issued for services for the quarter ending 2023-06-30 was $4.09M.
- Sunshine Biopharma Inc. stock issued during period, value, issued for services for fiscal 2023 was $4.09M.
- Sunshine Biopharma Inc. stock issued during period, value, issued for services for fiscal 2021 was $918.00K.
- Sunshine Biopharma Inc. stock issued during period, value, issued for services for fiscal 2019 was $57.39K, a 91.51% decline from fiscal 2018.
- Sunshine Biopharma Inc. stock issued during period, value, issued for services for fiscal 2018 was $676.10K, a 58.19% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $96.90K 10-Q · filed 2026-08-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $4.09M 10-K · filed 2025-04-01 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-05 | |
| 2023-06-30 | $4.09M 10-Q/A · filed 2024-08-20 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-04 | $918.00K 10-K · filed 2023-04-04 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | |
| 2021-03-31 | $918.00K 10-Q · filed 2022-05-06 | |
| 2020-09-30 | $50.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $50.00K 10-Q/A · filed 2020-08-31 | |
| 2019-12-31 | -$74.10K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $57.39K 10-K · filed 2021-03-30 |
| 2019-09-30 | $131.49K 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-01 | $676.10K 10-K · filed 2020-05-01 |
| 2018-09-30 | $192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | $690.50K derived: sum of 4 quarters · filed 2019-08-15 |
| 2018-06-30 | $484.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-15 | $847.50K derived: sum of 4 quarters · filed 2019-08-15 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-22 | $427.40K derived: sum of 4 quarters · filed 2019-04-12 |
| 2017-12-31 | $14.40K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-12 | $427.40K 10-K · filed 2019-04-12 |
| 2017-09-30 | $349.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | $695.80K derived: sum of 4 quarters · filed 2018-11-16 |
| 2017-06-30 | $64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-17 | $414.30K derived: sum of 4 quarters · filed 2018-08-17 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-22 | |
| 2016-12-31 | $282.80K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $702.30K 10-K · filed 2018-04-02 |
| 2016-09-30 | $67.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-15 | |
| 2015-12-31 | $66.50K 10-K · filed 2017-04-17 | |
| 2014-12-31 | $124.29K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $1.26M 10-K · filed 2016-03-25 |
| 2013-12-31 | $1.15M 10-K · filed 2015-03-11 | |
| 2012-12-31 | $272.88K 10-K · filed 2014-03-19 | |
| 2011-12-31 | $255.38K 10-K · filed 2014-03-19 | |
| 2010-12-31 | $237.20K 10-K · filed 2014-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |